I say keep the valuations coming guys.
Biomed is harder for me to rate. Reading Suga's post helps my understand 1) this is not a P&D, there is real substance because 2) PRR really believe in their product - they are listing on NASDAQ 3) by listing in the USA, PRR is looking for the investment opportunities to really market and develop their product. A good move for a good cause.
If you guys can justify $1 then that's worth a small punt from a guy like me who doesn't know biomed but does believe in the cause and knows that with C-Vac and many of the products being carried by PRR, success is possible.
So, keep the valuations coming guys and gals, as investors like me rely on your estimations to make considered purchases.
Newminer.
nasdaq listing perspective 101, page-5
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 388130 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 39940 | 3 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |